←ENLV · $0.65
Enlivex Therapeutics
ENLV · Pre-market
$0.65
-1.41% today·exchange $0.65
exchange $0.65
About
Enlivex Ltd. is an Israel-based clinical-stage macrophage reprogramming immunotherapy company focused on developing innovative cell therapies for sepsis, osteoarthritis, and psoriatic arthritis.
- Industry
- Healthcare
- CEO
- Oren Hershkovitz